Showing 8,961 - 8,980 results of 12,700 for search '"cancer"', query time: 0.10s Refine Results
  1. 8961

    The Health Benefits of Grapefruit Furanocoumarins by Yu Wang, Laura E. Reuss

    Published 2018-08-01
    “…Numerous studies have shown that furanocoumarins, reduce inflammation and stop cancer cells from multiplying. Furthermore, they may also help repair damaged DNA that would otherwise contribute to the development of tumors.  …”
    Get full text
    Article
  2. 8962

    Supplement 2 Section Dental Medicine by Christiana Madjova, Iliyana Atanasova

    Published 2024-12-01
    “…Supplement 2 Section Dental Medicine Proceedings of Supplement JofIMAB Publications of papers presented in the Scientific Programme of the 14-th Southeast European Conference Infections and Cancer Ohrid, North Macedonia, 3-6 October 2024 …”
    Get full text
    Article
  3. 8963
  4. 8964
  5. 8965

    Supplement 1 Section Medicine by Katerina Spasovska, Ralitsa Lechova-Dimitrova

    Published 2025-12-01
    “…Supplement 1 Section Medicine Proceedings of Supplement JofIMAB Publications of papers presented in the Scientific Programme of the 14-th Southeast European Conference Infections and Cancer Ohrid, North Macedonia, 3-6 October 2024…”
    Get full text
    Article
  6. 8966

    Living without Lymph Nodes by Martha C. Monroe, K. Roberts, Barbara F. Shea

    Published 2009-04-01
    “…Shea, helps women understand why lymph nodes are important, why sometimes it is necessary to sacrifice them, and recommends measures women can take to prevent or minimize infection and lymphedema after surgery for breast cancer. Includes additional sources of information and acknowledgments. …”
    Get full text
    Article
  7. 8967
  8. 8968
  9. 8969

    The Health Benefits of Grapefruit Furanocoumarins by Yu Wang, Laura E. Reuss

    Published 2018-08-01
    “…Numerous studies have shown that furanocoumarins, reduce inflammation and stop cancer cells from multiplying. Furthermore, they may also help repair damaged DNA that would otherwise contribute to the development of tumors.  …”
    Get full text
    Article
  10. 8970

    Living without Lymph Nodes by Martha C. Monroe, K. Roberts, Barbara F. Shea

    Published 2009-04-01
    “…Shea, helps women understand why lymph nodes are important, why sometimes it is necessary to sacrifice them, and recommends measures women can take to prevent or minimize infection and lymphedema after surgery for breast cancer. Includes additional sources of information and acknowledgments. …”
    Get full text
    Article
  11. 8971

    An Analysis of an Inflammatory Bowel Disease Practise in an Urban Community Hospital by David Adam, Jonathan Adam, Howard Price

    Published 2000-01-01
    “…The aspects studied were distribution of disease, need for hospital admission, immunosuppressants, systemic steroids, and surgery and its indications. The incidence of cancer was also reviewed.…”
    Get full text
    Article
  12. 8972
  13. 8973

    Epigenetics disruptions enabled by porphyrin-derived metal-organic frameworks disarm resistances to sonocatalytic ROS anti-tumor actions by Yan Zhang, Dou Du, Chao Fang, Xin Yu, Yujia Fang, Xinyu Liu, Di Ou, Haohao Yin, Hui Liu, Taixia Wang, Lu Lu, Xiaolong Li, Kun Zhang

    Published 2025-01-01
    “…The epigenetic deubiquitination disruption not only synergized with MOF-mediated sonocatalytic ROS production, but also inactivate deubiquitinating enzymes, blockade the deubiquitination process and further remove these resistances, both of which mutually behaved as reciprocal impetuses to significantly magnify SDT outcomes against liver cancers. Such a deubiquitination-engineered disruption approach finds an unprecedented pathway to disarm deubiquitination-induced resistances to SDT and other ROS-based anti-tumor means, which also enlightens us to establish other post-transcriptional epigenetic modification disruption strategies to re-program the tumor microenvironment and elevate the anti-tumor efficiency of various treatment methods (e.g., immunotherapy).…”
    Get full text
    Article
  14. 8974

    Profiling of Somatic Mutations in Phaeochromocytoma and Paraganglioma by Targeted Next Generation Sequencing Analysis by Andrea Luchetti, Diana Walsh, Fay Rodger, Graeme Clark, Tom Martin, Richard Irving, Mario Sanna, Masahiro Yao, Mercedes Robledo, Hartmut P. H. Neumann, Emma R. Woodward, Farida Latif, Stephen Abbs, Howard Martin, Eamonn R. Maher

    Published 2015-01-01
    “…To further elucidate the role of somatic mutation in PCC/PGL/HNPGL tumourigenesis, we employed a next generation sequencing strategy to analyse “mutation hotspots” in 50 human cancer genes. Mutations were identified for HRAS (c.37G>C; p.G13R and c.182A>G; p.Q61R) in 7.1% (6/85); for BRAF (c.1799T>A; p.V600E) in 1.2% (1/85) of tumours; and for TP53 (c.1010G>A; p.R337H) in 2.35% (2/85) of cases. …”
    Get full text
    Article
  15. 8975

    Mitochondrial dysfunction-driven AMPK-p53 axis activation underpins the anti-hepatocellular carcinoma effects of sulfane sulfur by Xue Zheng, Yuhua Luo, Rui Huo, Yiwen Wang, Youbang Chen, Mianrong Chen, Qi Zhao, Kexin Li, Hanyi Zhang, Xiaotong Li, Xiang Li, Hui Zhang, Zaopeng He, Li Huang, Chun-tao Yang

    Published 2025-01-01
    “…Abstract Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancer, notoriously refractory to conventional chemotherapy. …”
    Get full text
    Article
  16. 8976

    Evaluation of primary HPV-based cervical screening among older women: Long-term follow-up of a randomized healthcare policy trial in Sweden. by Qingyun Yao, Jiangrong Wang, K Miriam Elfström, Björn Strander, Joakim Dillner, Karin Sundström

    Published 2024-12-01
    “…<h4>Background</h4>Evidence on invasive cervical cancer prevention among older women is limited, especially with the introduction of human papillomavirus (HPV)-based screening and longer interval. …”
    Get full text
    Article
  17. 8977
  18. 8978
  19. 8979

    Case report: A severe myositis mimicking bulbar palsy after administration of immune checkpoint inhibitors by Philippe Rochigneux, Philippe Rochigneux, Alexandre Bertucci, Elika Loir, Alexia Mattei, Danielle Robert, Michael Dassa, Brice Chanez, Mikael Ebbo, Lea Gaigne, Anne Sophie Chretien, Giovanni Corazza, Giovanni Corazza, Nicolas Schleinitz

    Published 2025-02-01
    “…ObjectivesImmune Checkpoint Inhibitors (ICI) are nowadays a cornerstone of anti-cancer treatments. However, the wide spectrum of immune-related adverse events (irAEs) represents a challenge in the oncological practice. …”
    Get full text
    Article
  20. 8980